Tech Edge hosted a fireside chat on March 24 at Nasdaq MarketSite with Danny Brickman, Chief Executive Officer of Oasis Security. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed non-human identities and the security risks involved with...

By Karen Roman Private equity company Jeito Capital said it is co-leading an oversubscribed €77.7 million (USD 84.8 million) Series A financing round in Augustine Therapeutics. The founding will support Phase 2 of AGT-100216, Augustine’s main candidate for Charcot-Marie-Tooth disease...

Visit Exec Edge Research for the Full Report By Rayk Riechmann It’s time investors consider harvesting a new generation of profits from the vast American Corn Belt. Rex American Resources Corp. (NYSE: REX), a leading ethanol manufacturer with a stronghold...

Visit Exec Edge Research for Full Report By Rayk Riechmann As one of the brightest emerging biotechnology companies, Climb Bio Inc. (NASDAQ: CLYM) aims to improve the efficacy of autoimmune disease treatment. With its recently acquired lead asset, Budoprutug, and...

Digitally-native activewear startup Fabletics was founded in 2013 Company has grown revenue 30% annually, now approaching $900 million and is profitable Employs a unique VIP membership model that is free with big discounts, other perks VIP program helps Fabletics command...

By Daniella Parra Apollo Funds said it will acquire a majority stake in OEG Energy Group, an offshore energy services provider, from Oaktree Capital Management and other investors in a deal valued at over $1 billion. Vinson & Elkins advised...

By Karen Roman Sportradar Group AG (Nasdaq: SRAD) said it will acquire IMG ARENA’s global portfolio of sports betting rights by the fourth quarter, adding depth to its coverage of tennis, basketball and soccer. The company said the acquisition will...

By Karen Roman Waldencast plc (Nasdaq: WALD) said fourth quarter net revenue grew 30.8% to $72.1 million. Adjusted EBITDA doubled from the year prior to $11.2 million, or 15.5% of net revenue, driven by top-line performance and operational leverage, the...

By Daniella Parra Taiho Pharmaceutical said it will acquire Araris Biotech, a leader in antibody drug conjugates (ADCs), for an initial $400 million, with potential additional milestone payments of up to $740 million. Araris’ AraLinQ platform enhances ADC drug design,...

By Exec Edge Editorial Staff The fast-growing sector of iGaming has its share of success stories, but few can match the rocket-like trajectory of SPRIBE under David Natroshvili’s leadership. We sat down with the founder and CEO to discuss SPRIBE’s...